Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
3 hedge funds and large institutions have $3K invested in Onconova Therapeutics, Inc. Warrants in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
40% less capital invested
Capital invested by funds: $5K → $3K (-$2K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.21K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$588 |
ONTXW Hedge Fund Activity: Q3 2020 in Review
3 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q3 2020, worth a combined $3K — down 40% from $5K a quarter earlier.
Fund positioning in ONTXW was balanced in Q3 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $1.21K.
- 3 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $3K of Onconova Therapeutics, Inc. Warrants stock for Q3 2020, down 40% quarter-over-quarter.
- 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q3 2020 and 0 closed out.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q3 2020 was Susquehanna International Group, an estimated $1.21K sold.
Based on aggregated 13F filings for Q3 2020.